AbbVie Inc. Increases Humira Prices, Receives FDA Approval For New Drug By: TalkMarkets January 23, 2017 at 12:01 PM EST AbbVie company has announced its decision to hike the price of its Humira drug by over 8%. Read More >> Related Stocks: AbbVie